Search:
    
  • Click-based amplification: designed to facilitate various target labelling with ultralow background

    photos-ishc24

    Jinyi Bai , Fusheng Guo , Mengyao Li , Yulong Li * and Xiaoguang Lei*
    Received 6th January 2021 , Accepted 18th March 2021
    First published on 20th March 2021

    We here describe a fluorescent signal amplification method termed “Click-based amplification” that can be well integrated with various click-labelling modes, including chemical labelling, genetic incorporation and covalent inhibitor probe mediated target labelling. Picolyl azide (pAz) was used as a functional group of a streptavidin-based amplifier to enhance the efficiency of click chemistry. Click-based amplification provided 3.0–12.7 fold amplification on fixed HeLa cells with different click-labelling modes. Click-based amplification has proven to be superior to tyramide signal amplification (TSA) in view of its low nonspecific amplification and high signal-to-noise ratio. Moreover, in terms of the challenging signal amplification of tissue specimens, Click-based amplification successfully achieved remarkable fluorescence enhancement on intestinal tissue slices of afatinib-N3 treated mice, which provided direct evidence of the presence of afatinib-N3 in the intestinal tissues and helped in revealing the off-target toxicity of afatinib. Collectively, these results illustrate that Click-based amplification could serve as a promising method for bioimaging studies

  •  
  • New Strategies in the Efficient Total Syntheses of Polycyclic Natural Products

    photos-ishc24

    Polycyclic natural products are an inexhaustible source of medicinal agents, and their complex molecular architecture renders challenging synthetic targets where innovative and effective approaches for their rapid construction are urgently required. The total synthesis of polycyclic natural products has witnessed exponential progression along with the emergence of new synthetic strategies and concepts, such as sequential C−H functionalizations, radical-based transformations, and functional group pairing strategies. Our group exerts continued interest in the construction of bioactive and structurally complex natural products as well as evaluation of the mode of action of these molecules. In this Account, we will showcase how these new synthetic strategies are employed and guide our total synthesis endeavors. During the last two decades, a series of remarkable advances in C−H functionalization have led to the emergence of many new approaches to directly functionalize C−H bonds into useful functional groups. These selective transformations have provided a great opportunity for the step- and atom-economical construction of key fragments in complex molecule synthesis. We recently furnished the total syntheses for polycyclic natural products: incarviatone A, chrysomycin A, polycarcin V, and gilvocarcin V by employing a multiple C−H bond functionalization strategy. The polysubstituted benzene or naphthalene skeleton was constructed through sequential and site-selective C−H functionalizations from readily available simple starting materials, which reduced the number of steps and streamlined synthesis.

  •  
  • A pseudopaline fluorescent probe for the selective detection of Pseudomonas aeruginosa

    The rise of resistance against all known antibiotics is a global crisis. There is an urgent need to develop rapid and sensitive diagnostic methods to detect pathogenic bacteria in clinical samples. Pseudopaline, a metallophore produced by the human pathogen Pseudomonas aeruginosa, transports divalent metal ions via a dedicated active transport system, making it an ideal carrier for a second functional moiety. In this work, we have developed a fluorescein-labeled pseudopaline probe (P-FL), which could specifically detect P. aeruginosa in samples (in vitro) with many other bacterial species, mammalian cells, or mouse stomach tissue sections. By replacing the fluorescein with the near-infrared fluorophore Cy-7 (P-Cy7), we showed that P. aeruginosa infections could also be specifically detected in a mouse model (in vivo). The remarkable selectivity of these pseudopaline fluorescent probes is because the pseudopaline-mediated metal transport system is specific to P. aeruginosa only. Therefore, our results show that pseudopaline based probes may provide a new way to develop fast and effective diagnostics of P. aeruginosa infections.

  •  
  • Chemoenzymatic Total Syntheses of Artonin I with an Intermolecular Diels–Alderase

    photos-ishc24

    Xiaojing Liu, Jun Yang, Lei Gao, Liyun Zhang, and Xiaoguang Lei

    Diels–Alder reaction is one of the most important transformations used in organic synthesis, with the ability to construct two new C–C bonds and up to four chiral centers simultaneously. However, the biggest synthetic challenge in Diels–Alder reaction lies in controlling its regio-, diastereo-, and enantioselectivity.Using Stille cross-coupling and enzymatic Diels–Alder reaction as the key steps, the first chemoenzymatic total synthesis of artonin I is achieved in 30% overall yield over only seven steps. This enzymatic Diels–Alder reaction catalyzed by MaDA is featured with excellent endo- and enantioselectivity and high catalytic efficiency (kcat/KM = 362 ± 54 mm−1 s−1). These successful chemoenzymatic total syntheses of artonin I and dideoxyartonin I demonstrated the remarkable potential of the intermolecular Diels–Alderase MaDA in biocatalysis.

  •  
  • Syntheses of Skeletally Diverse Tetracyclic Isodon Diterpenoid Scaffolds Guided by Dienyne Radical Cyclization Logic

    Weilong Liu, Zongwei Yue, Zhen Wang, Houhua Li, and Xiaoguang Lei

    We report herein the diversity-oriented synthesis of various tetracyclic Isodon diterpenoid scaffolds guided by radical cyclization logic. Our substrate-based dienyne radical cyclization approach is distinctive from reagent-based rearrangement approaches that are generally applied in biosynthesis or previous synthetic studies. An unprecedented cyclization at C14 via 1,5- radical translocation/5-exo-trig cyclization is observed, which enriches our radical cyclization pattern. Furthermore, biological evaluations revealed that several new natural product-like compounds showed promising anticancer activities against various cancer cell lines.

  •  
  •  
  • FAD-dependent enzyme-catalysed intermolecular [4+2] cycloaddition in natural product biosynthesis

    photos-ishc24

    Lei Gao, Cong Su, Xiaoxia Du, Ruishan Wang, Shuming Chen, Yu Zhou, Chengwei Liu, Xiaojing Liu, Runze Tian, Liyun Zhang, Kebo Xie, She Chen, Qianqian Guo, Lanping Guo, Yoshio Hano, Manabu Shimazaki , Atsushi Minami, Hideaki Oikawa, Niu Huang, K. N. Houk, Luqi Huang*, Jungui Dai* and Xiaoguang Lei*
    Nature Chem. 2020, https://doi.org/10.1038/s41557-020-0467-7

    The Diels–Alder reaction is one of the most powerful and widely used methods in synthetic chemistry for the stereospecific construction of carbon–carbon bonds. Despite the importance of Diels–Alder reactions in the biosynthesis of numerous secondary metabolites, no naturally occurring stand-alone Diels–Alderase has been demonstrated to catalyse intermolecular Diels– Alder transformations. Here we report a flavin adenine dinucleotide-dependent enzyme, Morus alba Diels–Alderase (MaDA), from Morus cell cultures, that catalyses an intermolecular [4+2] cycloaddition to produce the natural isoprenylated flavonoid chalcomoracin with a high efficiency and enantioselectivity. Density functional theory calculations and preliminary measurements of the kinetic isotope effects establish a concerted but asynchronous pericyclic pathway. Structure-guided mutagenesis and docking studies demonstrate the interactions of MaDA with the diene and dienophile to catalyse the [4+2] cycloaddition. MaDA exhibits a substrate promiscuity towards both dienes and dienophiles, which enables the expedient syntheses of structurally diverse natural products. We also report a biosynthetic intermediate probe (BIP)-based target identification strategy used to discover MaDA.

  •  
  • Identification of the AMA Synthase from the Aspergillomarasmine A Biosynthesis and Evaluation of Its Biocatalytic Potential

    photos-ishc24

    Qianqian Guo, Dongshan Wu, Lei Gao, Yingjie Bai, Yuan Liu, Nianxin Guo, Xiaoxia Du, Jun Yang, Xiaoming Wang, and Xiaoguang Lei

    ACS Catal. 2020, https://doi/10.1021/acscatal.0c01187

    The β-lactam antibiotic resistance has become a critical global health threat. One of the major reasons for drug resistance is the expression of β-lactamases especially metallo-β-lactamases such as New Delhi metallo-β-lactamase (NDM-1) by Gram-negative bacteria. The fungal natural product aspergillomarasmine A (AMA) was found to be a promising inhibitor of NDM-1 to potentiate currently used β-lactam antibiotics to overcome drug resistance both in vitro and in vivo. Although several chemical synthesis and chemoenzymatic synthesis approaches to access AMA have been reported, the biosynthesis of AMA was still elusive. Herein, we identified the key enzyme responsible for the biosynthesis of AMA in Aspergillus oryzae. AMA synthase is a PLP-dependent cysteine synthase homologous protein which utilizes O-acetyl-Lserine/O-phospho-L-serine and L-aspartic acid as its substrates. Remarkably, this enzyme catalyzes two consecutive C-N bond formations to produce AMA efficiently which may be attributed to the spacious substrate-binding pocket. PLP is covalently bound to Lys61 by an internal aldimine from the PLP re face, and the si face of PLP pyridine ring is accessible to the substrates to promote the nucleophilic addition of amino acids to the double bond of the external adiminine and ultimately to generate chiral Cα with S configuration. The catalytic mechanism was proposed based on molecular docking and biochemical experiments. In addition, we have further investigated the substrate scope of AMA synthase and identified a variant enzyme which shows promising potential in producing structurally diverse molecules containing C-N bond.

  •  
  • Chrysomycin A Derivatives for the Treatment of Multi-Drug- Resistant Tuberculosis

    photos-ishc24

    Fan Wu, Jing Zhang, Fuhang Song, Sanshan Wang, Hui Guo, Qi Wei, Huanqin Dai, Xiangyin Chen, Xuekui Xia, Xueting Liu, Lixin Zhang, Jin-Quan Yu, and Xiaoguang Lei*
    ACS Cent. Sci. 2020, https://dx.doi.org/10.1021/acscentsci.0c00122

    Tuberculosis (TB) is a life-threatening disease resulting in an estimated 10 million new infections and 1.8 million deaths annually, primarily in underdeveloped countries. The economic burden of TB has been estimated as approximately 12 billion USD annually in direct and indirect costs. Additionally, multi-drug-resistant (MDR) and extreme-drug-resistant (XTR) TB strains resulting in about 250 000 deaths annually are now widespread, increasing pressure on the identification of new anti-TB agents that operate by a novel mechanism of action. Chrysomycin A is a rare C-aryl glycoside first discovered over 60 years ago. In a recent highthroughput screen, we found that chrysomycin A has potent anti-TB activity, with minimum inhibitory concentration (MIC) = 0.4
    μg/mL against MDR-TB strains. However, chrysomycin A is obtained in low yields from fermentation of Streptomyces, and the mechanism of action of this compound is unknown. To facilitate the mechanism of action and preclinical studies of chrysomycin A, we developed a 10-step, scalable synthesis of the isolate and its two natural congeners polycarcin V and gilvocarcin V. The synthetic
    sequence was enabled by the implementation of two sequential C−H functionalization steps as well as a late-stage C-glycosylation. In addition, >10 g of the advanced synthetic intermediate has been prepared, which greatly facilitated the synthesis of 33 new analogues to date. The structure−activity relationship was subsequently delineated, leading to the identification of derivatives with
    superior potency against MDR-TB (MIC = 0.08 μg/mL). The more potent derivatives contained a modified carbohydrate residue which suggests that further optimization is additionally possible. The chemistry we report here establishes a platform for the development of a novel class of anti-TB agents active against drug-resistant pathogens.

  •  
  • Late-Stage Diversification of Natural Products

    photos-ishc24

    Benke Hong, Tuoping Luo, Xiaoguang Lei*
    ACS Cent. Sci. (Cover Story) https://doi.org/10.1021/acscentsci.9b00916

    Late-stage diversification of natural products is an efficient way to generate natural product derivatives for drug discovery and chemical biology. Benefiting from the development of site-selective synthetic methodologies, late-stage diversification of natural products has achieved notable success. This outlook will outline selected examples of novel methodologies for site-selective transformations of reactive functional groups and inert C–H bonds that enable late-stage diversification of complex natural products. Accordingly, late-stage diversification provides an opportunity to rapidly access various derivatives for modifying lead compounds, identifying cellular targets, probing protein–protein interactions, and elucidating natural product biosynthetic relationships.

  •